Endocarditis

I9_ENDOCARD

endocarditis: Inflammation of the endocardium.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I33, I38, I39* Hospital discharge: ICD-9 — 421\|4249\|0932A Hospital discharge: ICD-8 — 421 Cause of death: ICD-10 — I33, I38, I39* Cause of death: ICD-9 — 421\|4249\|0932A Cause of death: ICD-8 — 421 2 out of 7 registries used, show all original rules.	1333
4. Check minimum number of events None	1333
5. Include endpoints None	1333
6. Filter based on genotype QC (FinnGen only)	1333

Control definitions (FinnGen only)

Control exclude: I9_OTHHEART

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF6

NAME	I9_ENDOCARD
CONTROL_EXCLUDE	I9_OTHHEART
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I33\|I38\|I39
HD_ICD_9	421\|4249\|0932A
HD_ICD_8	421
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I33\|I38\|I39
COD_ICD_9	421\|4249\|0932A
COD_ICD_8	421
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Endocarditis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	11617	4095	7361
Only index persons	8098	2778	5320
Unadjusted period prevalence (%)
Whole population	0.17	0.12	0.21
Only index persons	0.17	0.10	0.20
Median age at first event (years)
Whole population	63.81	67.80	61.53
Only index persons	61.72	64.49	60.28

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1333	397	936
Unadjusted period prevalence (%)	0.33	0.14	0.41
Median age at first event (years)	62.91	60.48	63.94

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1194: Matched controls
11939

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I50.9

ICD-10 Finland

Heart failure, unspecified

159.4

323.0

374

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

+∞

323.0

771

I48

ICD-10 Finland

Atrial fibrillation and flutter

182.0

323.0

500

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

18.8

323.0

603

613

B01AA03

ATC

warfarin; systemic

28.6

323.0

701

564

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

93.7

323.0

614

133

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

286.6

323.0

332

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

1623.8

323.0

347

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

13.7

292.5

584

780

I35.0

ICD-10 Finland

Aortic (valve) stenosis

188.4

283.3

287

207

Kela drug reimbursment

Chronic arrhythmias

249.7

272.5

271

C03CA01

ATC

furosemide; systemic

9.8

260.5

671

1381

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

48.2

258.3

315

I33.9

ICD-10 Finland

Acute endocarditis, unspecified

+∞

256.7

237

I38

ICD-10 Finland

Endocarditis, valve unspecified

+∞

244.3

226

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

934.6

240.4

228

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

76.5

226.1

254

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

527.6

225.9

218

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

10.4

224.6

510

796

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

210.8

196

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

8.2

205.5

564

1172

I50.0

ICD-10 Finland

Congestive heart failure

208.2

204.2

207

C07AB07

ATC

bisoprolol; oral

6.6

197.6

810

2886

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

210.1

191.2

194

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

262.6

178.7

179

TFP20

NOMESCO Finland

Cardiodefibrillation

194.7

178.2

182

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

+∞

171.0

160

C01AA05

ATC

digoxin; systemic

34.2

170.0

224

WX872

NOMESCO Finland

Intensive care

19.7

167.1

262

168

GD1AA

NOMESCO Finland

Thorax X-ray examination

5.5

164.6

794

3144

I34.1

ICD-10 Finland

Mitral (valve) prolapse

259.6

157.3

158

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

358.3

156.8

155

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

13.2

148.6

277

267

R50.9

ICD-10 Finland

Fever, unspecified

7.3

148.1

415

815

A49.9

ICD-10 Finland

Bacterial infection, unspecified

8.0

144.0

368

627

ZXD05

NOMESCO Finland

Urgent procedure

5.0

137.6

608

2045

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

+∞

137.1

129

A41.9

ICD-10 Finland

Sepsis, unspecified

16.7

137.1

228

166

K78

ICPC

Atrial fibrillation/flutter

36.6

133.8

173

I50.1

ICD-10 Finland

Left ventricular failure

719.5

133.3

129

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

64.3

127.0

147

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

632.7

118.2

115

A41.8

ICD-10 Finland

Other specified sepsis

33.0

117.8

156

A40.8

ICD-10 Finland

Other streptococcal sepsis

85.3

117.0

130

201

Kela drug reimbursment

Chronic cardiac insufficiency

30.7

115.6

156

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

11.1

114.8

231

252

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

+∞

114.4

108

C03DA01

ATC

spironolactone; oral

8.9

113.0

261

364

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

293.8

106.7

107

XF404

NOMESCO Finland

Ambulatory ECG

12.6

104.0

195

182

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

+∞

103.7

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

139.1

96.6

102

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.1

96.0

481

1675

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

31.8

94.5

126

I44.2

ICD-10 Finland

Atrioventricular block, complete

+∞

90.8

K83

ICPC

Heart valve disease NOS

245.8

89.8

B01AB05

ATC

enoxaparin; parenteral

3.7

88.0

521

2059

TPH07

NOMESCO Finland

Cathetrisation of artery

5.8

86.1

273

580

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

306.0

84.8

ZXE20

NOMESCO Finland

More than three and less than five hours

4.9

84.4

319

825

XF400

NOMESCO Finland

ECG with 12 standard connections

4.6

83.5

336

927

ZXE30

NOMESCO Finland

More than five and less than seven hours

9.2

81.7

181

228

B01AF02

ATC

apixaban; oral

14.3

80.5

141

111

TPH04

NOMESCO Finland

Cathetrisation of vein

4.1

80.0

382

1234

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

+∞

79.0

TK800

NOMESCO Finland

Hemodialysis

23.0

78.7

115

WX408

NOMESCO Finland

General anesthesy, balanced

3.5

78.2

481

1915

AN1

Coronary angiography

5.4

77.1

260

587

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.4

75.7

320

915

AB2

AVR bio, stent

+∞

74.8

C01BD01

ATC

amiodarone; systemic

196.9

72.0

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

+∞

70.5

ZXE00

NOMESCO Finland

One hour or less

3.1

70.3

570

2722

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

+∞

68.4

WX892

NOMESCO Finland

Monitored bed care

6.9

66.4

178

297

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

4.4

64.4

268

742

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

+∞

64.1

I25.1

ICD-10 Finland

Atherosclerotic heart disease

3.4

62.7

384

1472

I49.5

ICD-10 Finland

Sick sinus syndrome

171.6

62.6

R4110

NOMESCO Finland

Physiotherapy

3.2

62.2

424

1757

XFE00

NOMESCO Finland

Epicardial ultrasonography

18.9

61.7

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

17.8

61.1

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

+∞

60.9

I34.01

ICD-10 Finland

Mitral (valve) regurgitation NOS or of specified cause, except rheumatic

+∞

60.9

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

16.9

59.9

AB1

AVR mechanical

+∞

59.9

K84

ICPC

Heart disease other

16.7

59.1

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

7.1

58.5

152

241

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

5.4

57.1

186

394

M03.6*I33.0

ICD-10 Finland

Arthropathy in infective endocarditis

+∞

56.7

I42.0

ICD-10 Finland

Dilated cardiomyopathy

+∞

54.6

R06.0

ICD-10 Finland

Dyspnoea

3.2

54.0

345

1340

AA1AD

NOMESCO Finland

CT of head and brain

3.0

53.9

383

1600

Q23.11

ICD-10 Finland

Bicuspid aortic valve

191.9

53.4

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

188.2

52.4

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

+∞

51.4

J01MA12

ATC

levofloxacin; systemic

3.2

51.4

321

1221

C09AA05

ATC

ramipril; oral

2.9

51.3

393

1716

JN4BD

NOMESCO Finland

Extensive body CT

3.9

51.1

235

700

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

14.3

51.0

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

9.8

50.7

106

118

A46

ICD-10 Finland

Erysipelas

3.6

50.6

259

844

I50

ICD-10 Finland

Heart failure

30.8

50.2

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.4

48.9

271

938

I44.1

ICD-10 Finland

Atrioventricular block, second degree

486.2

47.7

I48.2

ICD-10 Finland

Chronic atrial fibrillation

+∞

47.2

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

18.0

46.4

J01FF01

ATC

clindamycin; systemic

2.7

45.8

391

1802

Z49.1

ICD-10 Finland

Extracorporeal dialysis

19.5

45.8

A11CC03

ATC

alfacalcidol; systemic

13.1

45.7

D64.9

ICD-10 Finland

Anaemia, unspecified

4.0

45.4

200

569

4210A

ICD-9 Finland

Acute and subacute endocarditis, Acute and subacute bacterial endocarditis

+∞

45.1

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

233.4

44.2

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

+∞

44.0

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

10.6

43.8

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

442.9

43.5

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.4

43.4

520

2876

J04AB02

ATC

rifampicin; systemic

17.9

43.3

I48.1

ICD-10 Finland

Persistent atrial fibrillation

228.0

43.2

R04.0

ICD-10 Finland

Epistaxis

5.1

43.1

144

310

I47.2

ICD-10 Finland

Ventricular tachycardia

119.4

43.0

Z2221

NOMESCO Finland

Medical doctor

2.7

42.5

378

1772

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

+∞

41.9

XF640

NOMESCO Finland

16.8

41.7

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

30.3

41.2

Angiography of the heart and coronary arteries

5.0

40.6

139

307

N18.8

ICD-10 Finland

Other chronic renal failure

10.4

40.5

ZXE10

NOMESCO Finland

More than one and less than three hours

2.4

40.4

487

2673

SPAT1255

SPAT

Intravenous administration of medicine

4.7

40.1

145

339

AC4

MVP

+∞

39.8

42100

ICD-8 Finland

Acute and subacute endocarditis, Acute and subacute bacterial endocarditis

+∞

39.8

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

45.3

39.3

Z2446

NOMESCO Finland

Social worker

4.7

39.2

143

337

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.5

38.7

400

2017

N17.9

ICD-10 Finland

Acute renal failure, unspecified

7.5

38.3

132

B03XA02

ATC

darbepoetin alfa; parenteral

12.8

37.8

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

5.7

37.6

113

214

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

31.8

37.2

K99

ICPC

Cardiovascular disease other

12.1

36.9

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

19.2

36.0

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

130.6

35.9

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

4.9

35.5

123

274

A12AA04

ATC

calcium carbonate; oral

16.0

35.5

WX402

NOMESCO Finland

General anaesthesia

3.0

35.5

240

937

XF402

NOMESCO Finland

ECG with work load test

3.6

35.1

172

530

PD5BD

NOMESCO Finland

Extensive CT of aorta

12.7

35.0

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

6.3

34.7

164

J01CA04

ATC

amoxicillin; systemic

2.3

34.5

916

7030

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

4.0

34.4

149

413

Z3231

NOMESCO Finland

Registered nurse

2.4

34.2

379

1957

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

22.1

33.7

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

5.7

33.6

100

187

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.7

33.1

263

1130

I97.0

ICD-10 Finland

Postcardiotomy syndrome

76.4

33.0

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.6

33.0

162

499

M04AA01

ATC

allopurinol; systemic

3.0

32.9

215

816

ZXD10

NOMESCO Finland

Scheduled procedure

2.2

32.7

479

2806

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

6.9

32.5

127

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.5

32.2

167

537

N18.0

ICD-10 Finland

End-stage renal disease

17.1

32.2

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

325.2

32.0

GD1LA

NOMESCO Finland

90.1

31.9

Catheterization and pressure measurement of the right side of the heart

169.4

31.8

ZX120

NOMESCO Finland

Intravenous

3.6

31.7

157

486

C07AA07

ATC

sotalol; systemic

9.5

31.7

TPX10

NOMESCO Finland

Implantation of vascular injection port

7.2

31.5

114

FCA70

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft

+∞

31.4

AP2

Catheterization of the right side of the heart

+∞

31.4

A02BC02

ATC

pantoprazole; systemic

2.1

31.1

749

5361

B18.2

ICD-10 Finland

Chronic viral hepatitis C

15.6

31.1

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

320.7

31.0

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

87.4

30.9

ZXE40

NOMESCO Finland

More than seven and less than nine hours

9.0

30.7

Z3226

NOMESCO Finland

Physiotherapist

2.6

30.7

260

1154

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

15.8

30.6

H02AB06

ATC

prednisolone; systemic

2.1

30.4

548

3477

TK810

NOMESCO Finland

Hemofiltration

28.2

30.3

TFP34

NOMESCO Finland

Electrophysiological investigation

+∞

30.3

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

8.8

30.3

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

309.7

29.9

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

309.7

29.9

A40.9

ICD-10 Finland

Streptococcal sepsis, unspecified

84.8

29.9

C01BC04

ATC

flecainide; systemic

158.9

29.8

A28

ICPC

Limited function/disability NOS

2.7

29.7

230

968

WW502

NOMESCO Finland

Autotransfusion

38.1

29.4

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

12.0

29.3

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

+∞

29.3

FKC50

NOMESCO Finland

Repair of mitral valve for insufficiency using prosthetic chord

+∞

29.3

V03AE01

ATC

polystyrene sulfonate; oral

12.9

29.2

Catheterization and pressure measurement of the left side of the heart

9.1

29.2

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.6

28.9

141

430

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.9

28.8

218

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

5.9

28.7

150

C07AB02

ATC

metoprolol; systemic

2.5

28.7

269

1256

J01CF05

ATC

flucloxacillin; systemic

5.6

28.5

164

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

4.7

28.4

100

226

J01MA14

ATC

moxifloxacin; systemic

3.5

28.4

143

448

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

14.2

28.2

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

+∞

28.2

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

+∞

28.2

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

+∞

28.2

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

5.2

28.1

184

M46.4

ICD-10 Finland

Discitis, unspecified

25.1

28.0

R07.4

ICD-10 Finland

Chest pain, unspecified

2.3

27.9

323

1675

N02BE01

ATC

paracetamol; systemic, rectal

2.2

27.5

985

8081

AP1

Catheterization of the left side of the heart

14.4

27.3

AC1

MVR mechanical

+∞

27.2

FKC60

NOMESCO Finland

Resection and reconstruction of leaflet of mitral valve for insufficiency

+∞

27.2

Aortic Valve Replacement (AVR)

+∞

27.2

N19

ICD-10 Finland

Unspecified kidney failure

6.1

27.1

132

A12BA01

ATC

potassium chloride; oral

5.1

27.1

187

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

4.5

26.9

234

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

4.7

26.8

212

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.1

26.6

159

563

WX002

NOMESCO Finland

Sedation and analgesia

2.4

26.4

262

1251

196

Kela drug reimbursment

Paricalcitol and cinacalcet

30.0

26.4

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.1

26.2

365

2044

C01DA14

ATC

isosorbide mononitrate; oral

2.6

26.2

215

930

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

3.2

26.1

149

511

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

26.1

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.6

26.1

124

370

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

4.1

26.1

107

281

I49.3

ICD-10 Finland

Ventricular premature depolarization

9.4

25.9

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

4.6

25.9

215

FCA50

NOMESCO Finland

Resection and reconstruction of ascending aorta using tube graft

266.0

25.8

I47.1

ICD-10 Finland

Supraventricular tachycardia

24.7

25.8

EBA15

NOMESCO Finland

Extraction of large number of teeth

5.0

25.7

180

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

25.6

368

2088

JN4AD

NOMESCO Finland

Body CT examination

3.3

25.4

136

445

Z50.0

ICD-10 Finland

Cardiac rehabilitation

18.3

25.4

AS4

Physiological pacemaker insertion DDD (R)

+∞

25.1

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

4.4

25.0

227

J01DB01

ATC

cefalexin; oral

2.1

25.0

926

7487

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

28.2

24.5

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

3.0

24.4

151

545

M46.3

ICD-10 Finland

Infection of intervertebral disc (pyogenic)

35.3

24.3

TKC20

NOMESCO Finland

Catheterisation of bladder

3.4

24.1

123

388

42792

ICD-8 Finland

Symptomatic heart disease, Fibrillatio auricularis

+∞

24.0

FGC10

NOMESCO Finland

Annuloplasty of tricuspid valve using prosthetic ring

+∞

24.0

XF600

NOMESCO Finland

Bloodpressure measurement

4.0

23.9

100

267

A07AA09

ATC

vancomycin; oral

13.6

23.8

AJ1

Reconstruction of the aortic base, eg composite graft, incl. valve saving operation

244.5

23.7

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.6

23.7

113

338

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

27.3

23.6

WW500

NOMESCO Finland

Blood transfusion

4.7

23.6

188

C09AA02

ATC

enalapril; systemic

2.2

23.4

280

1454

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

47.7

23.4

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.7

23.3

105

300

I34.8

ICD-10 Finland

Other nonrheumatic mitral valve disorders

+∞

23.0

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

23.0

C09DX04

ATC

valsartan and sacubitril; oral

+∞

23.0

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.7

22.9

106

309

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

4.7

22.8

176

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

6.2

22.5

102

B99

ICD-10 Finland

Other and unspecified infectious diseases

6.5

22.4

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.7

22.3

102

295

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

4.7

22.0

169

FKC96

NOMESCO Finland

Other repair of mitral valve for insufficiency

+∞

21.9

I33

ICD-10 Finland

Acute and subacute endocarditis

+∞

21.9

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

5.7

21.8

118

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

117.1

21.6

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.6

21.5

103

309

B01AB10

ATC

tinzaparin; parenteral

3.4

21.4

107

332

V03AE02

ATC

sevelamer; oral

23.6

21.3

H05BX01

ATC

cinacalcet; oral

21.2

21.3

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

8.6

21.3

N02AX02

ATC

tramadol; systemic, rectal

1.8

21.1

495

3318

JN3AD

NOMESCO Finland

Abdominal CT examination

3.3

21.0

112

365

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.7

20.9

154

619

FKC20

NOMESCO Finland

Plastic repair of mitral valve leaflet for insufficiency

+∞

20.9

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

+∞

20.9

UJF32

NOMESCO Finland

Coloscopy

2.0

20.6

318

1828

I45.9

ICD-10 Finland

Conduction disorder, unspecified

111.9

20.6

Z49.0

ICD-10 Finland

Preparatory care for dialysis

13.8

20.6

AA1

Conventional CABG

7.3

20.3

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

13.3

20.2

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

5.3

20.2

121

I10

ICD-10 Finland

Essential (primary) hypertension

1.8

20.0

681

5119

K77

ICPC

Heart failure

21.2

20.0

A10AE04

ATC

insulin glargine; parenteral

2.8

20.0

137

529

X59

ICD-10 Finland

Exposure to unspecified factor

2.2

19.9

233

1189

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

+∞

19.8

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

19.8

258

1382

3A064

NOMESCO Finland

74.7

19.7

NHQ40

NOMESCO Finland

Amputation of toe

8.1

19.6

TQW11

NOMESCO Finland

Vacuum treatment of wound

7.5

19.6

R02

ICPC

Shortness of breath/dyspnoea

2.7

19.5

138

543

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

3.0

19.4

116

409

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

3.0

19.4

119

426

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.8

19.2

134

521

J01XX08

ATC

linezolid; systemic

18.5

19.1

SPAT1254

SPAT

Administration of medicine

2.3

19.1

189

891

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.0

18.9

113

398

205

Kela drug reimbursment

Chronic hypertension

1.9

18.9

371

2320

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

5.4

18.8

110

AC2

MVR bio

+∞

18.8

4219X

ICD-9 Finland

Acute and subacute endocarditis, Acute endocarditis, unspecified

+∞

18.8

V03AE03

ATC

lanthanum carbonate; oral

28.3

18.8

WW200

NOMESCO Finland

Immunization

5.4

18.6

107

FM1CD

NOMESCO Finland

Very extensive CT of heart

192.8

18.6

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.1

18.5

242

1294

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.3

18.5

184

869

P19

ICPC

Drug abuse

15.3

18.5

3AC01

NOMESCO Finland

15.3

18.5

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.0

18.5

280

1587

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.3

18.4

313

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.1

18.4

109

380

R31

ICD-10 Finland

Unspecified haematuria

2.5

18.4

157

683

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.9

18.3

212

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

4.5

18.3

154

I44.0

ICD-10 Finland

Atrioventricular block, first degree

25.5

18.3

B01AC04

ATC

clopidogrel; oral

2.2

18.2

212

1077

R53

ICD-10 Finland

Malaise and fatigue

2.1

18.0

227

1194

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.4

17.8

276

WX882

NOMESCO Finland

High dependency care

5.1

17.8

117

GE1BE

NOMESCO Finland

Mediastinal ultrasound examinaiton through oesophagus

67.6

17.8

5273

FHL

Repair with flap prosthesis or graft

+∞

17.7

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

6.0

17.7

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

96.4

17.6

N05CF01

ATC

zopiclone; oral

1.8

17.6

378

2422

GAE10

NOMESCO Finland

Closure of previous incision of chest wall

182.5

17.6

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.4

17.5

158

711

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.7

17.4

125

495

ZXA00

NOMESCO Finland

Right side

1.9

17.4

324

1978

M10.9

ICD-10 Finland

Gout, unspecified

3.1

17.2

335

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.3

17.1

174

827

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

32.0

17.1

E87.5

ICD-10 Finland

Hyperkalaemia

8.4

17.0

EBA10

NOMESCO Finland

Surgical removal of tooth

2.5

16.9

138

588

A03

ICPC

Fever

2.3

16.9

171

814

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

16.8

192

965

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

64.2

16.8

R60.0

ICD-10 Finland

Localized oedema

2.5

16.7

136

578

Mitral valve Replacement (MVR)

+∞

16.7

4241A

ICD-9 Finland

Other diseases of endocardium, Aortic valve disorders[INSUFFICIENTIA VALVULAE AORTAE (NON RHEUMATICA)]

+∞

16.7

4240A

ICD-9 Finland

Other diseases of endocardium, Mitral valve disorders[INSUFFICIENTIA VALVULAE MITRALIS (NON RHEUMATICA)]

+∞

16.7

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

+∞

16.7

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

5.0

16.6

113

WX722

NOMESCO Finland

PEEP

3.8

16.6

194

WX213

NOMESCO Finland

Lower leg blockade

16.6

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

16.6

Z95.4

ICD-10 Finland

Presence of other heart-valve replacement

172.2

16.5

Z94.0

ICD-10 Finland

Kidney transplant status

9.7

16.5

A40.0

ICD-10 Finland

Sepsis due to streptococcus, group A

23.4

16.5

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

3.6

16.4

223

K92.1

ICD-10 Finland

Melaena

3.3

16.3

278

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

3.0

16.2

331

WX730

NOMESCO Finland

Conventional respirator

7.8

16.2

PC1BD

NOMESCO Finland

Extensive CT of thoracic aorta

30.5

16.1

XF622

NOMESCO Finland

Measurement of minute volume of heart

30.5

16.1

FL1AC

NOMESCO Finland

Left cardioangiography

8.0

16.1

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

13.8

16.0

I25.2

ICD-10 Finland

Old myocardial infarction

3.1

16.0

317

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

4.4

15.9

137

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.9

15.9

279

1661

742

NOMESCO Finland

60.8

15.8

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

9.9

15.7

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

5.7

15.7

I35

ICD-10 Finland

Nonrheumatic aortic valve disorders

+∞

15.7

T82.6

ICD-10 Finland

Infection and inflammatory reaction due to cardiac valve prosthesis

+∞

15.7

AS2

Ventricular pacemaker insertion VVI (R)

+∞

15.7

WX110

NOMESCO Finland

Local anesthesy

1.7

15.6

712

5633

FC1BC

NOMESCO Finland

Extensive angiography of thoracal aortta

86.2

15.6

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

11.9

15.6

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

8.7

15.5

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

9.6

15.5

J01CF02

ATC

cloxacillin; systemic

5.2

15.4

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

15.4

337

2155

C08CA01

ATC

amlodipine; oral

1.7

15.3

420

2879

C02AC05

ATC

moxonidine; oral

3.5

15.3

209

127

Kela drug reimbursment

Transplant complication

7.0

15.2

I71.00

ICD-10 Finland

Dissecting aneurysm of aorta (ruptured) [any part]

23.7

15.1

L04AA06

ATC

mycophenolic acid; systemic

6.6

15.0

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

4.1

14.9

151

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

14.9

514

3748

Z71.8

ICD-10 Finland

Other specified counselling

1.9

14.8

239

1376

R4120

NOMESCO Finland

Occupational therapy

3.1

14.8

286

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.7

14.8

188

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

4.2

14.7

139

R55

ICD-10 Finland

Syncope and collapse

2.4

14.6

131

583

R00.1

ICD-10 Finland

Bradycardia, unspecified

6.4

14.6

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

+∞

14.6

AD1

TVP

+∞

14.6

AJ2

Reconstruction of the ascending aorta

+∞

14.6

Mitral valve plasty

+∞

14.6

I51.4

ICD-10 Finland

Myocarditis, unspecified

+∞

14.6

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

4.5

14.6

116

FXG00

NOMESCO Finland

Insertion and use of IABP

81.1

14.6

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

151.7

14.5

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

7.7

14.5

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

12.7

14.4

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.7

14.4

366

2443

Z72.2

ICD-10 Finland

Drug use

19.4

14.2

SPAT1104

SPAT

Monitoring of emergency patient

2.9

14.2

306

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

14.0

179

941

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

16.0

13.9

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.9

13.9

317

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

30.4

13.9

XA800

NOMESCO Finland

Neuropsychological investigation

3.7

13.9

172

WZC30

NOMESCO Finland

Teaching

2.1

13.9

165

839

PD5AD

NOMESCO Finland

CT of aorta

8.3

13.8

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

13.8

136

635

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

13.8

179

945

ZXA05

NOMESCO Finland

Left side

1.8

13.7

289

1816

WX212

NOMESCO Finland

Femoral plexus blockade

6.3

13.7

R2110

NOMESCO Finland

Giving the first information

3.1

13.7

251

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

+∞

13.6

I48.3

ICD-10 Finland

Typical atrial flutter

+∞

13.6

FXA10

NOMESCO Finland

Total cardiopulmonary bypass in deep hypothermia at concurrent surgical procedure

+∞

13.6

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

+∞

13.6

S97

ICPC

Chronic ulcer skin

3.0

13.6

269

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

34.4

13.5

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.0

13.5

N02AA05

ATC

oxycodone; systemic

2.0

13.5

184

990

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

7.9

13.4

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.8

13.4

274

1705

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

10.6

13.3

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

6.4

13.3

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.5

13.3

184

L28

ICPC

Limited function/disability (L)

2.0

13.2

177

946

KA1AE

NOMESCO Finland

Kidney ultrasound examination

4.6

13.2

100

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

13.2

238

1421

I35.8

ICD-10 Finland

Other aortic valve disorders

40.5

13.2

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

40.5

13.2

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.7

13.2

159

H02AB07

ATC

prednisone; oral

2.1

13.1

160

823

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

15.2

13.1

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

8.4

13.1

5253

FHL

Cardiac lung machine

11.1

13.0

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

16.9

13.0

A40.1

ICD-10 Finland

Sepsis due to streptococcus, group B

28.7

13.0

K02.9

ICD-10 Finland

Dental caries, unspecified

5.3

12.9

137

Kela drug reimbursment

Uraemia requiring dialysis

10.6

12.8

I49.1

ICD-10 Finland

Atrial premature depolarization

9.8

12.7

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

3.0

12.7

252

GD1AD

NOMESCO Finland

Thorax CT examination

3.4

12.7

191

WX870

NOMESCO Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

296

225

16.63

307.65

7.3

2.4

u/ml

0.3

1.34

213

114

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

790

2239

7.21

290.66

5.4

1.9

ng/l

3533.3

659.3

12.96

741

1828

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

218

112

23.07

288.02

8.2

6.6

mg/l

12.3

11.2

1.69

207

101

(3023368) Bacteria identified in Blood by Culture

839

2679

6.75

266.00

13.9

3.9

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

236

171

16.56

263.27

1.7

1.8

—

(3020779) Urea [Moles/volume] in Serum or Plasma

436

760

8.04

257.05

14.2

5.7

mmol/l

11.8

8.9

9.67

424

720

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

510

1050

7.25

256.44

3.7

4.1

u/l

285.0

241.8

4.23

492

984

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

491

1103

6.46

222.48

4.8

2.1

19.5

24.3

10.42

431

947

(3018677) aPTT in Platelet poor plasma by Coagulation assay

544

1362

6.06

218.78

4.8

2.0

32.4

28.8

23.68

531

1325

(3004789) Transferrin [Mass/volume] in Serum or Plasma

501

1182

6.19

214.56

4.7

2.0

g/l

2.1

2.3

6.20

484

1091

(3032080) INR in Blood by Coagulation assay

927

3718

5.90

212.09

32.3

4.6

inr

1.8

1.1

41.25

304

984

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

354

598

7.70

211.94

4.0

1.9

ng/l

401.6

91.6

11.89

337

528

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

296

410

8.99

210.80

2.2

1.6

g/l

1.4

1.5

0.36

237

351

(3042936) Bacteria identified in Isolate by Culture

518

1295

5.91

207.28

3.4

2.0

—

(3022217) INR in Platelet poor plasma by Coagulation assay

426

896

6.52

205.22

52.0

10.4

inr

2.0

1.1

8.63

163

(3022948) Iron [Moles/volume] in Serum or Plasma

511

1285

5.83

202.59

4.8

2.1

umol/l

10.4

13.7

20.30

493

1188

(3027456) Digoxin [Moles/volume] in Serum or Plasma

103

53.07

179.41

3.2

2.0

nmol/l

0.9

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

348

679

6.58

179.24

2.8

1.9

ug/l

15.9

6.4

6.57

324

572

(3027945) Reticulocytes/100 erythrocytes in Blood

444

1092

5.60

177.98

3.4

2.4

1.9

1.7

2.68

419

954

(3003458) Phosphate [Moles/volume] in Serum or Plasma

440

1169

5.13

159.24

14.8

5.0

mmol/l

1.2

1.0

13.18

415

1084

(3012095) Magnesium [Moles/volume] in Serum or Plasma

483

1397

4.85

157.17

6.1

3.3

mmol/l

0.8

0.77

456

1300

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

189

225

9.62

150.16

4.9

2.8

g/l

3.8

3.7

0.21

180

214

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

186

219

9.71

149.01

2.0

1.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

611

2300

4.06

136.21

3.2

2.0

mg/l

3.3

2.9

2.74

550

1900

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

470

1480

4.36

134.21

2.4

1.7

—

(3023520) Reticulocytes [#/volume] in Blood

333

809

5.15

131.97

3.7

2.4

e9/l

66.4

66.5

0.01

252

615

(42870588) Differential panel, method unspecified - Blood

727

3223

3.76

124.38

11.5

5.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

168

218

8.67

124.04

4.6

2.7

219.4

191.3

2.35

161

208

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

363

1010

4.56

120.75

16.2

6.8

kpa

5.0

5.2

1.72

345

963

(3027801) Oxygen [Partial pressure] in Arterial blood

363

1011

4.56

120.58

16.2

6.8

kpa

11.8

12.5

1.79

347

965

(3003396) Base excess in Arterial blood by calculation

362

1008

4.56

120.25

16.3

6.8

mmol/l

1.0

1.1

0.07

294

769

(3022096) Basophils/100 leukocytes in Blood

857

4312

3.77

118.80

12.2

6.1

0.6

0.7

0.75

834

3971

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

359

1007

4.51

117.92

2.2

1.7

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

23.82

117.26

1.4

1.1

iu/ml

4.9

—

(3006504) Eosinophils/100 leukocytes in Blood

867

4422

3.75

117.05

12.5

6.0

2.9

0.08

844

4077

(3019069) Monocytes/100 leukocytes in Blood

869

4441

3.75

116.91

12.8

6.3

9.1

8.9

1.05

847

4111

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

478

1677

3.88

114.79

6.4

2.9

ng/l

2861.6

587.4

0.75

445

1315

(3000991) Gas panel - Venous blood

299

740

4.92

114.77

18.1

7.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

355

1007

4.44

114.63

2.2

1.7

—

(3002030) Lymphocytes/100 leukocytes in Blood

875

4551

3.69

113.17

12.5

6.1

21.3

27.8

58.50

850

4197

(3036489) Thrombin time

188

312

6.85

111.22

4.5

2.2

22.9

20.9

2.20

178

280

(3001604) Monocytes [#/volume] in Blood

886

4692

3.65

110.31

12.0

5.6

e9/l

0.7

0.6

8.82

816

3982

(3006315) Basophils [#/volume] in Blood

888

4718

3.64

109.79

12.1

5.7

e9/l

0.0

0.68

820

4010

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

204

374

6.26

109.28

2.7

1.7

ug/l

1.5

3.1

0.87

185

329

(3019198) Lymphocytes [#/volume] in Blood

899

4846

3.63

107.88

12.0

5.8

e9/l

1.6

2.0

5.53

829

4192

(3018010) Neutrophils/100 leukocytes in Blood

857

4490

3.54

107.56

12.2

5.9

62.7

57.0

34.96

831

4167

(3016502) Oxygen saturation in Arterial blood

326

911

4.41

106.73

17.5

7.2

96.1

95.9

0.14

318

874

(3021447) Carbon dioxide [Partial pressure] in Venous blood

309

834

4.52

105.79

8.9

3.4

kpa

5.7

5.8

0.20

297

813

(3013115) Eosinophils [#/volume] in Blood

898

4882

3.57

105.30

12.5

5.9

e9/l

0.2

0.24

829

4219

(3002032) Base excess in Venous blood by calculation

308

833

4.51

105.13

9.9

3.4

mmol/l

1.6

1.9

0.72

264

640

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

265

639

4.93

104.40

2.0

1.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

912

5043

3.56

103.22

10.0

6.4

umol/l

12.9

11.9

1.41

883

4774

(3002173) Hemoglobin [Mass/volume] in Arterial blood

303

843

4.36

99.24

18.4

7.7

g/l

110.6

123.3

17.95

298

808

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

630

2852

3.29

98.34

3.0

2.0

u/l

303.7

231.8

0.65

604

2668

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

201

405

5.67

97.05

10.6

4.4

mmol/l

23.7

24.2

0.98

183

367

(3001122) Ferritin [Mass/volume] in Serum or Plasma

729

3623

3.23

96.55

5.1

2.4

ug/l

209.4

164.7

3.39

694

3299

(3014111) Lactate [Moles/volume] in Serum or Plasma

290

796

4.38

96.52

14.7

6.3

mmol/l

1.3

0.39

274

766

(46235355) HIV 1 and 2 tests - Meaningful Use set

383

1341

3.60

89.44

2.5

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

211

493

4.90

85.53

21.7

9.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

162

301

5.99

84.95

3.8

2.2

ug/l

1514.0

400.9

0.60

155

285

(3024561) Albumin [Mass/volume] in Serum or Plasma

777

4208

3.03

84.87

9.8

4.6

g/l

31.7

35.5

43.81

736

3889

(3020630) Protein [Mass/volume] in Serum or Plasma

272

780

4.12

84.61

2.3

2.7

g/l

64.9

67.1

3.69

257

713

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

851

4869

3.07

83.66

18.8

5.9

mmol/l

1.2

14.88

726

4108

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

792

4391

2.98

81.84

17.5

5.3

mmol/l

1.2

19.95

753

3928

(3009445) Proteinase 3 Ab [Units/volume] in Serum

170

345

5.50

80.96

1.3

1.5

u/ml

3.4

29.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

613

2974

2.96

80.93

4.7

3.3

u/l

38.9

33.5

1.85

594

2811

(3013650) Neutrophils [#/volume] in Blood by Automated count

914

5546

3.06

78.75

15.5

9.1

e9/l

4.8

4.2

10.35

847

4794

(3044640) Blood type and Crossmatch panel - Blood

617

3095

2.85

75.16

4.7

2.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

934

5821

3.02

74.95

12.8

4.1

mmol/l

7.0

6.8

1.54

905

5414

(3007853) Bacteria identified in Skin by Aerobe culture

314

1074

3.52

74.73

2.7

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

286

930

3.64

73.48

2.4

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

440

1880

3.00

71.66

3.0

1.7

mg/l

2.0

1.4

2.06

380

1455

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

295

999

3.51

71.02

6.1

3.0

—

(3019060) Gas panel - Arterial blood

211

570

4.21

70.50

11.5

5.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

658

3501

2.74

70.20

6.5

2.8

ng/l

70.9

58.6

0.39

531

2490

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

190

476

4.49

70.08

17.8

8.1

mmol/l

24.3

24.4

0.34

180

449

(3033658) Prothrombin time (PT) actual/Normal

525

2494

2.82

69.87

10.0

3.7

72.5

91.8

38.41

517

2444

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

117

191

6.62

69.60

1.8

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

224

648

3.95

67.98

2.1

2.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

117

197

6.41

67.49

2.6

3.4

umol/l

34.1

36.5

0.52

107

174

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

126

229

5.97

67.26

1.5

1.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

113

185

6.58

66.99

1.8

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

503

2382

2.79

66.77

4.4

2.4

—

(3024928) Oxygen saturation in Venous blood

103

154

7.16

66.51

7.3

4.7

—

(3024354) Oxygen [Partial pressure] in Venous blood

231

698

3.79

65.74

6.7

3.1

kpa

5.1

4.5

3.07

220

682

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

300

1090

3.26

63.93

2.5

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

104

8.55

63.77

1.9

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

17.21

63.66

2.6

1.1

mg/l

3395.1

70.9

0.49

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

125

240

5.64

62.89

1.7

1.3

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

666

3711

2.59

62.60

5.0

3.2

—

(3018418) pH of Serum or Plasma

554

2831

2.64

62.28

9.8

3.5

7.4

0.14

140

507

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

117

213

5.93

62.27

1.4

1.2

iu/ml

7.5

6.8

—

(3002582) Erythrocytes [#/volume] in Urine

593

3132

2.61

62.26

4.9

3.1

e6/l

74.4

101.9

0.53

497

2420

(3026782) Osmolality of Urine

439

2002

2.78

61.90

4.0

2.6

mosm/kgh2o

522.4

588.1

8.00

401

1691

(3030467) Casts [#/volume] in Urine by Automated count

553

2846

2.61

60.98

4.6

3.0

e6/l

0.5

0.4

0.17

459

2143

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

259

886

3.39

60.66

2.9

2.5

g/l

0.2

6.84

235

834

(40758558) Short blood count panel - Blood

484

2340

2.68

60.58

12.9

6.8

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

196

567

3.88

59.11

20.1

8.0

0.6

0.7

0.70

196

562

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

765

4634

2.53

59.01

7.1

4.0

—

(3012441) Differential panel - Pleural fluid

10.79

58.28

1.8

1.3

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

195

572

3.82

57.58

20.0

7.9

1.4

1.3

0.09

195

567

(36304419) Bacteria [Presence] in Urine

533

2756

2.56

57.46

4.6

3.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

166

6.36

57.21

1.4

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

166

6.36

57.21

1.4

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

197

586

3.77

56.98

1.7

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

9.09

56.88

1.9

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

130

283

4.98

56.66

2.3

3.4

ratio

1.2

2.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

26.75

56.41

18.2

6.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

213

675

3.57

55.99

2.7

2.4

g/l

12.0

10.8

2.14

202

613

(3000850) Epithelial cells [#/volume] in Urine

448

2154

2.63

55.93

3.8

2.4

e6/l

5.5

4.3

1.11

411

1886

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

131

291

4.88

55.72

2.4

3.4

mg/l

53.4

67.8

0.29

104

246

(3034860) Kappa light chains.free [Mass/volume] in Serum

131

291

4.88

55.72

2.4

3.4

mg/l

66.6

42.7

2.55

102

245

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

129

7.06

55.25

2.0

1.6

—

(3018095) Leukocytes [#/volume] in Urine

632

3584

2.45

55.19

5.7

3.6

e6/l

54.2

106.9

1.93

508

2572

(3038071) Oxygen [Partial pressure] in Mixed venous blood

29.25

55.14

18.6

6.9

—

(3028026) IgM [Mass/volume] in Serum or Plasma

184

537

3.82

54.62

1.8

g/l

1.1

1.4

1.09

174

486

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

103

194

5.67

52.76

1.7

1.4

—

(3021589) Normoblasts [#/volume] in Blood

705

4265

2.39

52.35

24.1

8.7

e9/l

0.0

0.20

604

3492

(3004119) Hemoglobin [Mass/volume] in Venous blood

182

550

3.67

51.21

7.5

3.1

g/l

113.3

130.1

13.08

176

534

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

274

1066

2.98

50.93

3.3

3.1

umol/l

11.2

9.3

0.60

236

951

(40760888) Immunoglobulin light chains.free panel - Serum

106

212

5.35

50.82

2.6

3.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

176

5.80

50.58

4.9

5.2

iu/ml

307.0

9366.6

0.51

(3037522) Nuclear Ab [Titer] in Serum

267

1036

2.97

49.78

1.5

1.3

titre

692.0

440.4

1.01

211

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

548

3020

2.38

49.73

3.4

2.6

u/l

57.5

58.1

0.09

514

2774

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

177

536

3.65

49.59

1.8

1.4

—

(3012501) Base excess in Blood by calculation

176

5.74

49.49

8.3

3.3

mmol/l

2.4

2.2

0.32

117

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

139

355

4.25

49.49

1.9

2.3

g/l

7.5

7.4

0.13

107

262

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

139

355

4.25

49.49

1.9

2.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

138

355

4.22

48.64

1.9

2.3

g/l

4.2

3.9

1.14

104

255

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

137

6.39

48.63

1.5

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

134

338

4.30

48.47

1.9

2.3

g/l

12.0

10.4

1.91

114

286

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1044

7667

2.67

48.30

16.5

7.2

u/l

92.7

80.2

7.87

1017

7142

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

194

635

3.41

48.15

8.2

3.4

ng/l

170.8

80.3

10.15

175

553

(3010421) pH of Blood

104

215

5.16

48.00

8.5

3.1

7.4

0.33

172

(3008152) Bicarbonate [Moles/volume] in Arterial blood

177

550

3.56

47.62

17.3

6.9

mmol/l

24.0

24.5

0.78

172

503

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

130

325

4.32

47.56

1.7

2.3

g/l

3.8

3.1

6.34

106

259

(40767503) Oxygen content in Capillary blood by calculation

161

5.85

47.52

3.5

2.2

15.3

16.7

1.33

(3045788) Cell count panel - Pleural fluid

10.37

47.14

1.6

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

127

318

4.31

46.34

2.3

2.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

8.87

45.85

1.5

1.3

e6/l

27794.6

66233.7

0.54

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

116

273

4.56

45.81

1.4

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

156

5.82

45.77

1.7

1.4

u/ml

114.9

109.0

0.18

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

117

6.64

45.18

1.6

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

9.64

44.72

2.1

1.4

—

(1616796) Gas panel - Central venous blood

172

5.47

44.25

6.4

2.9

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

173

5.44

43.97

1.8

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

113

269

4.50

43.96

1.4

2.3

g/l

0.1

0.0

0.23

100

247

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

152

5.76

43.72

1.3

u/ml

299.5

236.4

1.09

(3000494) Fungus identified in Specimen by Culture

269

1124

2.75

43.19

1.8

1.4

—

(40768806) Pleura Pathology biopsy report

8.34

42.92

1.6

1.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

8.15

42.82

1.6

1.2

e6/l

8739.4

2907.1

0.34

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

108

254

4.54

42.65

1.4

2.2

g/l

0.0

0.00

234

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

102

6.86

42.37

1.6

1.4

—

(3031040) Bacteria [#/volume] in Urine by Automated count

912

6484

2.29

42.23

6.2

4.2

e6/l

410.6

1933.7

0.88

106

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

106

250

4.52

41.70

1.4

2.3

g/l

0.0

0.00

234

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

118

304

4.16

41.38

1.8

2.3

g/l

0.6

1.6

1.24

104

264

(3026008) Bacteria identified in Urine by Culture

488

2727

2.25

41.13

3.9

3.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

462

2550

2.24

39.90

3.9

2.6

umol/l

3154.3

7161.8

1.35

421

2202

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

167

5.23

39.42

1.3

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

194

715

3.01

39.10

3.9

4.2

0.5

0.01

174

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

9.87

38.75

1.6

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

107

6.33

38.12

1.6

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

10.54

37.92

1.7

1.5

—

(3017181) Myelocytes/100 leukocytes in Blood

207

805

2.86

37.78

4.1

4.3

0.8

0.9

0.22

239

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

108

282

4.08

37.13

1.4

2.2

g/l

32.7

38.0

10.72

243

(3019309) Folate [Moles/volume] in Red Blood Cells

374

1941

2.29

37.04

2.0

1.7

nmol/l

1209.8

1147.9

0.53

302

1449

(3019768) Coxiella burnetii Ab [Presence] in Serum

+∞

36.63

1.3

0.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

10.29

36.39

1.7

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

7.32

35.78

1.3

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

163

576

3.08

35.22

2.2

1.6

—

(3042733) HLA Ab [Presence] in Serum

16.13

34.95

5.3

3.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

9.58

34.59

2.0

1.5

—

(3037756) Immunofixation for Serum or Plasma

191

4.63

34.52

1.3

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

124

378

3.51

34.05

13.3

5.8

2.0

1.6

2.42

118

354

(3013707) Erythrocyte sedimentation rate by Westergren method

961

7280

2.15

33.70

6.9

3.7

mm/h

23.4

11.8

41.71

928

6643

(3048929) Epstein Barr virus Ab [Presence] in Serum

246

4.08

32.99

1.4

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

190

758

2.76

32.81

4.1

4.4

0.1

0.87

218

(3025159) Blasts/100 leukocytes in Blood

183

716

2.80

32.80

3.9

4.4

0.3

0.2

0.20

178

(3021960) Folate [Moles/volume] in Serum or Plasma

419

2371

2.12

32.79

1.9

1.5

nmol/l

18.7

20.2

1.07

380

1991

(3039000) Anion gap in Blood

199

4.44

32.78

18.2

8.4

mmol/l

10.9

11.0

0.09

175

(3018572) Chloride [Moles/volume] in Blood

199

4.44

32.78

18.3

8.4

mmol/l

105.6

105.5

0.07

175

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

325

1667

2.26

32.57

3.9

3.0

e6/l

2.2

1.7

0.48

194

921

(3047181) Lactate [Moles/volume] in Blood

269

3.90

32.16

17.1

7.2

mmol/l

1.2

1.3

0.34

232

(3007930) Methemoglobin/Hemoglobin.total in Blood

120

374

3.43

31.80

13.8

5.8

1.0

0.9

0.94

114

350

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

10.54

31.66

1.2

1.1

iu/ml

200.8

253.8

0.26

(3037467) Urinalysis macro (dipstick) panel - Urine

917

6910

2.05

31.42

6.1

4.0

—

(44790048)

6.01

30.25

1.5

—

(44790047)

6.01

30.25

1.5

—

(44806118)

6.01

30.25

1.5

—

(44790049)

6.01

30.25

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

253

3.88

30.15

5.8

3.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

123

5.24

29.88

1.6

1.2

u/ml

3.0

2.0

0.55

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

204

883

2.55

29.77

3.0

2.6

u/l

31.8

93.5

0.60

179

758

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

46.16

29.74

11.6

4.9

mmol/l

7.2

5.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

626

4198

1.93

29.53

2.4

1.9

pmol/l

91.2

93.2

0.56

368

2246

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

7.19

29.37

1.2

1.3

titre

281.4

176.9

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

152

573

2.87

29.09

7.5

3.0

mmol/l

1.6

1.4

0.24

110

406

(3007164) IgA [Mass/volume] in Serum or Plasma

316

1676

2.16

28.73

1.7

1.4

g/l

3.2

2.6

2.08

222

987

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

8.29

28.71

1.3

2.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

8.29

28.71

1.3

2.1

—

(3044889) 12 lead EKG panel

910

6964

1.97

28.18

7.1

3.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

128

448

3.05

27.95

8.5

2.4

mmol/l

24.6

24.8

0.21

123

430

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

8.07

27.35

3.5

1.8

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

153

603

2.74

26.85

7.7

3.0

kpa

5.0

5.1

1.45

148

554

(3009343) pH of Capillary blood

152

600

2.73

26.59

7.6

3.0

7.4

0.10

(3028707) Methadone [Presence] in Urine by Screen method

115

5.04

25.95

3.9

2.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

165

4.29

25.71

1.4

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

320

1773

2.06

25.58

3.6

2.8

e6/l

1.1

1.3

0.32

191

1020

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

162

4.30

25.45

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

125

4.81

25.40

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

119

4.87

24.94

1.6

1.2

u/ml

7.5

3.2

1.12

(3024891) Influenza virus A+B Ag [Presence] in Specimen

205

3.76

23.35

1.2

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

166

4.07

22.97

3.7

3.5

0.8

1.3

0.73

122

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

336

3.10

22.74

1.9

1.6

u/l

37.2

40.4

0.74

301

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

546

3719

1.79

22.73

3.0

2.1

nmol/l

75.6

77.1

0.51

503

3238

(3051651) Icteric interference index of Serum or Plasma

7.09

22.55

6.6

3.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

18.23

22.12

1.3

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

5.86

22.04

3.1

2.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

137

4.30

21.82

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

5.53

21.75

1.3

1.2

u/l

46.9

63.4

1.32

(3028626) Oxygen [Partial pressure] in Capillary blood

197

3.69

21.59

6.3

2.7

kpa

8.5

8.4

0.11

184

(3024471) HLA-A [Type]

10.17

21.20

1.0

—

(40768446) Kidney Pathology biopsy report

10.17

21.20

2.5

1.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

128

4.35

21.05

9.8

2.8

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

159

3.97

20.97

3.7

3.3

e9/l

4.6

4.1

0.86

159

(3015377) Calcium [Moles/volume] in Serum or Plasma

492

3310

1.77

20.93

4.5

3.4

mmol/l

2.3

2.4

9.44

438

2839

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

165

3.89

20.71

4.6

3.4

61.1

56.9

1.83

165

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

168

780

2.32

20.67

10.7

3.4

mmol/l

1.2

2.88

157

671

(3011288) Drugs identified in Urine by Screen method

171

3.82

20.47

7.2

3.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

159

730

2.34

20.06

2.5

2.3

nmol/l

386.7

371.8

0.38

152

670

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

9.38

20.02

1.9

2.2

—

(3035880) pH of Pleural fluid

8.27

19.68

1.8

1.2

—

(3002256) Pathology report gross observation

246

1351

2.01

19.65

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

11.93

19.61

1.3

1.1

—

(4268621)

5.13

19.59

2.8

2.2

—

(3024932) HLA-DR beta [Type]

9.34

19.13

1.0

1.1

—

(4198724)

8.71

18.93

2.5

1.6

—

(3042631) Mycobacterium sp identified in Specimen

130

4.12

18.92

2.6

2.7

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

28.27

18.76

8.5

8.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

12.03

18.72

1.4

—

(3021788) Differential panel - Synovial fluid

170

3.65

18.34

1.7

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

327

2026

1.81

17.91

6.2

4.4

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

37.25

17.64

1.4

1.2

—

(4062490)

5.18

17.47

1.4

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

5.18

17.47

1.4

1.2

g/l

0.4

0.02

(3028192) IgG subclass 2 [Mass/volume] in Serum

5.18

17.47

1.4

1.2

g/l

3.1

3.0

0.10

(3027135) IgG subclass 1 [Mass/volume] in Serum

5.18

17.47

1.4

1.2

g/l

9.0

6.4

1.12

(3023419) Bacteria identified in Sputum by Culture

117

4.13

17.21

2.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

6.48

17.14

1.5

1.2

—

(3021901) Oxygen saturation in Capillary blood

150

3.71

17.00

3.6

2.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

204

3.30

16.99

5.6

2.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

793

6295

1.64

16.78

5.4

3.0

u/l

81.2

53.0

7.42

751

5784

(3022313) Gas panel - Capillary blood

109

457

2.51

16.75

8.5

3.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

374

2.66

16.60

3.1

3.5

pmol/l

4.1

4.6

3.23

328

(21494890) Protein electrophoresis panel - 24 hour Urine

4.68

16.41

1.2

2.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

154

3.61

16.36

1.1

—

(3035350) Ketones [Presence] in Urine by Test strip

633

4773

1.62

16.34

4.5

3.4

estimate

0.0

0.00

162

876

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

159

3.56

16.33

1.1

—

(3016879) Cocaine [Presence] in Urine

242

3.04

16.19

5.9

2.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

4.78

15.94

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

5.94

15.75

1.7

1.5

u/l

9.9

4.6

0.71

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

6.51

15.41

2.9

3.7

—

(3000764) Benzodiazepines [Presence] in Urine

256

2.92

15.25

6.1

2.1

—

(3015736) pH of Urine

514

3731

1.61

15.19

3.9

3.2

—

5.9

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

5.70

15.12

1.6

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

129

3.74

15.07

1.5

g/l

0.8

0.07

106

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

102

4.12

15.04

3.3

4.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

406

2.50

14.95

2.7

1.7

—

(3027008) Opiates [Presence] in Urine

260

2.87

14.83

5.9

2.1

—

(3028300) Cannabinoids [Presence] in Urine

260

2.87

14.83

6.5

2.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

5.59

14.81

1.6

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

256

2.87

14.67

1.5

iu/ml

0.4

0.3

0.11

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

399

2.49

14.54

8.9

3.3

mmol/l

24.7

0.11

373

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1127

9972

1.84

14.45

50.0

12.5

mg/l

33.1

26.7

9.72

1057

7764

(3037121) Protein [Mass/volume] in Urine

334

2.62

14.40

3.7

3.4

g/l

0.5

0.2

1.37

143

(3027944) Amphetamines [Presence] in Urine

259

2.84

14.36

6.2

2.0

—

(3051611) Lipemic interference index of Serum or Plasma

4.38

14.35

7.4

3.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

8.68

14.15

1.1

1.3

ug/l

43.5

229.0

—

(3000012) Reticulocyte production index

6.48

14.13

1.3

1.4

—

(3020891) Body temperature

351

2.55

13.98

12.3

3.9

—

(3025941) Bacteria identified in Stool by Culture

102

451

2.37

13.95

1.2

—

(3013512) EKG study

411

2873

1.62

13.91

6.9

3.3

—

(3009261) Glucose [Presence] in Urine by Test strip

625

4830

1.55

13.67

4.7

3.4

estimate

0.0

0.50

162

845

(3009508) Creatinine [Moles/volume] in Urine

452

3247

1.59

13.60

4.1

3.2

mmol/l

6.6

8.1

10.01

396

2691

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

4.11

13.60

1.1

1.0

—

(3011412) CD3 cells [#/volume] in Blood

4.59

13.58

1.9

2.9

e9/l

1.1

0.09

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

5.94

13.55

1.7

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

5.94

13.55

1.7

1.5

—

(3050794) Legionella sp Ab [Presence] in Serum

26.03

13.38

1.2

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

4.64

13.33

1.6

—

(3051593) INR in Capillary blood by Coagulation assay

6.99

13.16

11.1

4.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

615

4766

1.54

13.09

6.3

4.6

estimate

0.0

0.50

167

897

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

128

3.52

12.98

1.2

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

114

3.68

12.92

1.8

1.5

77.2

63.0

1.97

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

261

2.69

12.51

1.7

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

5.08

12.44

1.7

3.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

122

3.52

12.42

2.7

4.0

—

(3033799) Differential panel - Peritoneal fluid

7.81

12.30

1.4

2.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

4.03

12.23

2.2

2.4

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

4.10

12.15

1.6

2.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

110

3.62

12.05

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

182

2.99

11.97

2.8

2.0

g/l

123.4

132.7

1.53

124

(3002385) Erythrocyte distribution width [Ratio]

951

8187

1.56

11.90

54.6

15.6

14.7

13.6

50.51

936

7994

(4306422)

121

3.46

11.85

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

386

2.34

11.82

2.5

1.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

6.14

11.68

2.4

2.0

—

(3034426) Prothrombin time (PT)

7.16

11.43

1.2

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

171

3.00

11.39

1.3

u/l

63.9

37.6

0.31

142

(40761536) Microorganisms panel - Urine sediment

145

799

1.91

11.19

6.1

3.4

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

25.25

11.15

1.1

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

25.25

11.15

1.1

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

3.93

11.14

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

4.70

10.97

1.7

3.1

8.7

13.9

1.29

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

249

2.61

10.97

2.7

1.8

—

(3011648) Oxygen content in Venous blood

4.15

10.90

4.6

6.5

9.6

10.4

0.39

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

3.73

10.72

1.1

—

(3025315) Body weight

21.65

10.69

4.5

1.9

—

(3044007) Cell count panel - Peritoneal fluid

7.57

10.57

1.5

2.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

673

5475

1.46

10.42

3.2

2.6

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

6.07

10.40

1.5

2.9

e6/l

411.3

414.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

3.75

10.18

1.9

1.5

13.1

23.2

1.47

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

3.66

10.12

1.8

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

3.57

10.08

1.8

1.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

271

1839

1.59

9.92

4.0

3.2

mmol/l

2.5

2.4

0.32

225

1623

(3015171) Extractable nuclear Ab [Units/volume] in Serum

262

2.47

9.90

1.4

1.2

u/ml

4.8

0.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

9.31

9.88

5.4

4.7

—

(3003181) Sodium [Moles/volume] in Urine

152

2.96

9.88

1.8

1.3

mmol/l

52.2

68.2

2.03

127

(3020191) Ethanol [Moles/volume] in Serum or Plasma

3.83

9.80

1.8

1.5

promille

1.3

1.1

0.17

(3019832) Treponema pallidum Ab [Presence] in Serum

110

577

1.99

9.79

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

164

2.87

9.77

1.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

3.78

9.63

1.2

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

4.48

9.57

1.7

2.8

e6/l

386.4

770.6

1.18

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

4.06

9.53

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

6.22

9.47

1.5

2.3

e6/l

53706.2

442.1

—

(3003694) ABO and Rh group [Type] in Blood

369

2722

1.49

9.15

1.4

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

116

3.16

9.11

3.3

3.6

70.8

55.5

4.13

(3004451) EKG impression Narrative

5.06

9.11

1.5

1.2

—

(3019977) pH of Arterial blood

4.52

8.85

2.6

3.3

7.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

4.92

8.37

2.3

2.0

umol/l

91.3

75.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

3.78

8.36

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

3.78

8.36

1.1

1.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

424

3263

1.44

8.30

4.6

3.9

mg/mmol

29.6

6.9

5.74

302

2123

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

6.14

8.19

1.0

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

4.57

8.13

1.7

1.4

3.1

2.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

6.55

8.07

1.2

—

(3012516) Albumin [Mass/volume] in Urine

404

3103

1.43

7.93

3.9

3.2

mg/l

877.4

258.9

1.28

301

1997

(3000475) Leukocytes [#/volume] in Synovial fluid

245

2.34

7.92

2.1

1.6

e6/l

28911.8

15865.6

1.13

169

(3010375) cycloSPORINE [Mass/volume] in Blood

4.66

7.89

11.9

26.6

ug/l

104.3

137.0

0.84

(3019550) Sodium [Moles/volume] in Serum or Plasma

1141

10529

1.58

7.85

55.7

14.3

mmol/l

138.8

139.7

27.51

1121

10201

(3009542) Hematocrit [Volume Fraction] of Blood

1002

9004

1.45

7.84

48.7

13.9

36.2

40.0

22.59

668

6180

(3017704) Immunofixation for Urine

4.09

7.82

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

180

1170

1.62

7.77

2.4

1.8

1.7

1.6

1.94

151

1019

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

128

760

1.76

7.75

3.4

2.7

ml/min/173m2

47.7

67.1

4.76

299

(3044941) Cell count panel - Synovial fluid

162

2.64

7.74

1.9

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

229

2.37

7.72

1.5

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

3.91

7.72

2.3

2.1

e6/l

285.6

798.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

274

2.25

7.69

1.4

ug/g

289.8

266.6

0.38

162

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

206

1394

1.57

7.50

1.4

1.2

iu/ml

40.6

37.2

0.14

420

(3029937) Albumin [Presence] in Urine by Test strip

348

2629

1.44

7.39

5.3

3.6

estimate

0.0

0.88

151

855

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.96

7.38

1.0

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

973

8731

1.42

7.38

4.8

4.1

mu/l

2.1

0.13

905

7795

(3023103) Potassium [Moles/volume] in Serum or Plasma

1141

10562

1.56

7.37

56.5

14.4

mmol/l

4.1

4.0

14.70

1121

10217

(40759836) Histone Ab [Presence] in Serum by Immunoblot

3.64

7.32

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

3.64

7.32

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

3.64

7.32

1.2

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

4.18

7.28

2.9

2.4

—

(3000492) Spirometry study

139

860

1.69

7.26

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

6.36

7.25

1.3

1.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

3.47

7.13

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

3.53

7.01

1.2

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

788

6856

1.37

6.99

3.9

3.4

pmol/l

14.8

0.09

730

6065

(3008536) Aspergillus sp Ab [Presence] in Serum

6.52

6.78

1.3

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

3.17

6.73

1.1

1.3

—

(40768804) Tissue Pathology biopsy report

481

3898

1.37

6.64

2.5

2.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

255

1850

1.47

6.64

1.3

1.2

u/ml

2.5

1.4

0.68

456

(3016038) Potassium [Moles/volume] in Urine

3.68

6.48

1.6

1.2

mmol/l

43.2

32.4

0.78

(3044927) Protein electrophoresis panel - Urine

2.96

6.45

1.3

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

301

2265

1.42

6.43

3.8

3.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

334

2560

1.41

6.43

5.0

3.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

5.50

6.29

1.1

1.6

g/l

22.2

10.7

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

3.37

6.29

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

3.37

6.29

1.2

1.1

—

(3047189) Immunofixation for 24 hour Urine

3.99

6.18

1.1

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

127

2.64

6.16

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

127

2.64

6.16

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

127

2.64

6.16

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

127

2.64

6.16

1.5

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

3.23

6.16

1.8

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

3.23

6.16

1.8

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

3.23

6.16

1.8

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

12.58

6.08

1.6

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

128

2.62

6.07

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

128

2.62

6.07

1.5

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

158

2.45

6.07

1.3

1.2

u/ml

2.0

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

172

2.37

5.95

2.0

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

271

2.07

5.90

1.1

—

(40768797) Stomach Pathology biopsy report

188

1319

1.50

5.75

1.3

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

3.94

5.72

2.7

2.3

umol/l

62.8

50.9

0.88

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

268

2.06

5.69

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

275

2.04

5.68

1.1

—

(3017732) Neutrophils [#/volume] in Blood

108

668

1.67

5.67

3.7

3.5

e9/l

4.5

4.0

0.92

489

(3017569) Oxygen content in Arterial blood

4.09

5.63

1.6

3.7

—

(21494434) Karyotype in Bone marrow

2.83

5.59

1.1

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

3.37

5.45

1.9

2.8

40.7

36.9

—

(3052592) Norovirus Ag [Presence] in Stool

5.59

5.32

1.1

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

195

2.19

5.26

1.3

1.2

u/ml

4.3

12.8

0.69

(3026389) Candida sp identified in Specimen by Organism specific culture

2.72

5.02

1.6

1.4

—

(40757373) Influenza virus identified in Isolate

4.81

5.02

1.2

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

105

2.60

4.99

1.2

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

446

3698

1.31

4.94

5.2

3.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

194

2.15

4.92

1.3

1.2

u/ml

2.3

2.7

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

9.05

4.78

1.0

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

9.05

4.78

1.0

95.7

108.9

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

5.03

4.78

1.3

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.24

4.62

1.2

1.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1020

9467

1.33

4.59

39.5

12.0

ml/min/173m2

71.8

79.8

15.66

926

7633

(3014891) Appearance of Pleural fluid

14.06

4.58

2.4

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

284

2229

1.35

4.57

1.8

1.7

pmol/l

483.0

26185753.6

1.70

247

1856

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

4.79

4.53

2.1

3.1

—

(40768443) Skin Pathology biopsy report

374

1.78

4.47

1.2

—

(40761511) CBC panel - Blood by Automated count

1109

10436

1.37

4.46

42.9

11.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

483

1.68

4.39

2.4

2.3

—

(36660697) Celiac disease serology panel - Serum

101

657

1.58

4.38

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

4.26

4.36

1.9

2.8

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.57

4.30

1.2

1.8

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

8.93

4.28

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

201

2.02

4.15

1.2

1.3

miu/ml

234.4

226.2

0.04

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

104

2.43

4.07

1.6

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

8.04

4.06

1.4

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

181

1347

1.40

4.04

1.3

1.2

u/ml

36.2

11.5

0.44

511

(3030981) Hyaline casts [#/volume] in Urine by Automated count

584

1.58

3.97

4.7

2.7

e6/l

0.2

0.3

1.12

572

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

3.28

3.91

1.6

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

3.28

3.91

1.6

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

3.28

3.91

1.6

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

3.28

3.91

1.6

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.82

3.80

1.0

1.4

—

(3045142) Bone marrow Pathology biopsy report

114

2.31

3.79

1.1

1.4

—

(3042517) Benzodiazepines panel - Urine

12.05

3.76

11.0

1.2

—

(3022145) Colonoscopy Study observation

148

1078

1.42

3.74

1.5

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

110

2.30

3.63

1.6

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

7.81

3.56

2.7

1.3

ng/l

311.8

113.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

3.19

3.50

1.4

1.1

ratio

1.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

10.04

3.50

1.5

1.0

mg/l

6.3

12.9

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

396

1.65

3.45

1.2

—

(21494755) Public health laboratory ask at order entry panel

756

0.57

3.45

1.2

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

306

1.73

3.38

1.7

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

101

2.30

3.37

1.7

1.3

nmol/l

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

7.03

3.36

2.0

2.5

—

(3034988) Calcium [Moles/volume] in Capillary blood

4.76

3.24

5.2

1.8

mmol/l

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.59

3.20

3.3

1.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.59

3.20

3.3

1.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1129

10776

1.31

3.17

22.3

9.7

u/l

26.3

27.2

1.01

1107

10305

(3004616) Nuclear Ab [Presence] in Serum

104

2.23

3.17

1.2

—

(4281824)

2.56

3.13

1.3

1.2

—

(3022621) pH of Urine by Test strip

626

1.49

3.13

4.1

3.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

132

2.07

3.08

1.2

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

114

2.13

2.95

1.7

1.3

nmol/l

0.1

0.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

2.29

2.94

1.5

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

2.29

2.94

1.7

1.3

e6/l

77498.3

118566.8

0.17

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

147

1118

1.35

2.90

3.2

4.5

ug/l

14.9

28.5

0.66

121

938

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1127

10784

1.29

2.88

50.3

14.8

umol/l

113.7

80.2

21.54

1127

10777

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

6.69

2.87

1.0

2.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

503

0.53

2.84

1.4

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

123

2.05

2.82

4.6

1.9

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.78

2.82

1.2

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

991

9358

1.23

2.76

7.1

5.8

mmol/mol

41.0

40.0

1.97

948

8551

(3035285) Chloride [Moles/volume] in Venous blood

125

2.02

2.72

4.6

1.8

mmol/l

105.1

105.4

0.14

125

(3041354) Potassium [Moles/volume] in Venous blood

125

2.02

2.72

4.6

1.8

mmol/l

4.1

0.01

125

(3049717) Cytology report of Urine Cyto stain

505

1.49

2.68

2.3

3.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

4.69

2.60

1.6

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.62

2.57

2.1

1.9

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.52

2.53

2.5

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

108

2.05

2.52

1.3

1.4

pmol/l

237.1

255.3

0.12

(3019150) Specific gravity of Urine by Refractometry

258

2154

1.25

2.51

4.9

3.7

kg/l

1.0

2.17

312

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

3.48

2.48

1.3

1.2

ug/l

19.4

373.4

—

(40768800) Prostate Pathology biopsy report

391

0.50

2.48

1.1

1.2

—

(3014271) Vancomycin [Susceptibility]

2.56

2.44

3.2

2.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

2.30

2.41

1.2

—

(40768441) Liver Pathology biopsy report

2.36

2.39

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

290

1.61

2.39

3.6

4.3

—

(3017509) Phencyclidine [Presence] in Urine

6.27

2.37

1.4

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

6.27

2.37

1.0

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

2.43

2.37

1.2

1.4

g/l

1.0

0.02

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

671

0.63

2.37

1.3

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.51

2.36

2.7

2.9

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

4.13

2.36

1.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.87

2.30

1.5

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.87

2.30

1.5

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.87

2.30

1.5

1.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.47

2.28

1.1

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

4.63

2.27

1.3

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.49

2.27

1.3

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.90

2.25

1.3

2.9

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.12

2.22

2.3

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

5.57

2.21

1.0

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.35

2.18

2.4

2.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.35

2.18

1.3

1.2

—

(3005570) Glucose [Moles/volume] in Urine

101

2.00

2.16

2.0

1.8

—

(3048689) Calprotectin [Mass/mass] in Stool

130

1019

1.31

2.13

2.6

2.4

ug/g

180.0

150.9

0.24

112

794

(4034850)

331

0.51

2.12

30.7

8.7

—

(3000330) Specific gravity of Urine by Test strip

506

1.43

2.12

3.7

3.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.57

2.10

1.1

—

(4035726)

113

871

1.32

2.09

1.6

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

117

1.90

2.07

1.1

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

752

0.68

2.03

1.6

1.8

—

(3001019) Free T4 and TSH panel - Serum or Plasma

309

0.51

1.96

1.1

1.6

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

3.76

1.93

5.7

2.2

mmol/l

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

405

4510

0.85

1.92

4.0

4.5

22.8

21.7

0.67

188

2317

(3006442) Creatine [Moles/volume] in Serum or Plasma

2.13

1.92

1.9

1.4

—

77.3

—

(3000034) Microalbumin [Mass/volume] in Urine

1.97

1.90

1.8

3.3

mg/l

39.9

16.8

0.46

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

114

1.86

1.87

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

2.22

1.84

2.6

1.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

985

9422

1.17

1.82

4.7

3.9

mmol/l

1.4

1.3

1.37

916

8468

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.18

1.82

1.4

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.18

1.82

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

2.01

1.80

1.6

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.77

1.79

1.0

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.18

1.78

1.0

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

217

1.58

1.74

1.2

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.14

1.72

1.0

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

219

1.57

1.69

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

2.19

1.67

1.0

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

119

1.78

1.66

1.3

1.7

—

(3035933) Granulocytes/100 leukocytes in Blood

3.17

1.66

1.5

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

960

0.75

1.66

1.5

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

291

0.54

1.66

1.6

—

(3045716) Anion gap in Serum or Plasma

2.34

1.60

2.4

1.6

mmol/l

8.4

9.1

—

(1761868) Lipid panel - Serum or Plasma

298

3350

0.86

1.56

3.1

2.9

—

(3002619) Bacteria identified in Specimen by Culture

2.87

1.50

1.5

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.87

1.50

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

1.50

0.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

292

3275

0.86

1.48

3.0

3.1

ug/l

0.9

0.8

0.41

207

2214

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1.82

1.47

1.7

1.3

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

2.23

1.46

2.0

2.9

u/l

324.7

201.5

—

(4133840)

2.73

1.43

1.2

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

643

1.29

1.41

1.4

1.9

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

165

1.59

1.41

1.8

1.9

iu/l

3.0

5.5

1.34

(3029075) Extractable nuclear Ab panel - Serum

2.42

1.39

1.0

—

(3006653) Thiamine [Moles/volume] in Blood

2.08

1.38

1.1

1.3

nmol/l

129.1

144.6

0.32

(3013139) Helicobacter pylori Ag [Presence] in Stool

583

1.30

1.38

1.1

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

264

1.45

1.37

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

121

0.41

1.37

1.0

1.5

—

(3008295) Osmolality of Serum or Plasma

1.81

1.37

1.8

1.7

mosm/kgh2o

278.4

283.3

0.35

(3044242) Glucose [Moles/volume] in Arterial blood

2.20

1.37

1.6

3.1

—

(3019225) pH of Specimen

127

1054

1.23

1.36

10.2

3.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

156

1322

1.20

1.36

1.5

1.4

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.95

1.36

1.0

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

112

1.71

1.35

3.7

3.2

nmol/l

22.9

2.7

0.89

112

(3047007) Chlamydophila sp Ab [Presence] in Serum

112

1.71

1.35

1.0

1.2

—

(3024263) Appearance of Synovial fluid

2.05

1.33

2.2

1.7

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.51

1.30

3.0

1.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.36

1.29

1.0

1.1

—

(4027681)

2.09

1.28

1.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.29

1.27

1.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.17

1.21

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

1.75

1.19

2.0

u/field

1.2

3.2

—

(3028433) Virus identified in Specimen by Culture

2.31

1.18

1.0

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.34

1.12

1.3

1.0

miu/ml

2167.1

1656.7

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.34

1.12

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.34

1.12

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

115

0.43

1.12

1.2

1.3

mmol/l

8.4

7.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.26

1.10

1.0

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.26

1.10

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.19

1.08

1.0

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

113

1330

0.84

1.05

4.4

4.5

31.0

31.6

0.22

832

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

288

2617

1.13

1.04

1.7

1.6

mmol/l

1.5

1.4

0.48

252

2187

(40768793) Breast Pathology biopsy report

147

0.54

1.04

1.0

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.28

1.03

1.0

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

113

1323

0.84

1.00

14.9

5.9

—

(3003338) MCHC [Mass/volume]

873

8424

1.11

0.99

58.0

16.6

g/l

328.7

333.6

40.48

863

8349

(3044290) Cell count panel - Cerebral spinal fluid

215

1.40

0.98

1.2

1.5

—

(3023410) Appearance of Cerebral spinal fluid

108

1.58

0.96

1.4

1.9

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1006

9787

1.11

0.95

4.9

4.3

mmol/l

1.3

1.4

13.10

937

8866

(4211845)

1.77

0.94

6.3

3.3

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

1.77

0.94

3.9

4.0

nmol/l

365.2

64.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1015

9881

1.11

0.94

5.0

4.3

mmol/l

4.2

4.6

28.04

950

9018

(3002523) Influenza virus A Ag [Presence] in Specimen

117

1.55

0.94

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

118

1.53

0.91

1.2

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.07

0.89

1.2

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

127

1.50

0.88

1.1

u/ml

5.3

2.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

458

1.26

0.88

1.2

iu/ml

116.3

137.3

0.14

169

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

380

0.73

0.87

1.9

1.7

nmol/l

41.1

40.5

0.06

366

(3013166) Neutrophils/100 leukocytes in Synovial fluid

2.00

0.87

2.0

1.3

72.5

60.6

—

(3016018) Differential panel - Cerebral spinal fluid

112

1.52

0.85

1.3

1.6

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.94

0.84

1.7

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.78

0.84

1.1

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

129

1.48

0.83

1.2

—

(3006462) Nitrate [Presence] in Urine

1.74

0.82

7.0

3.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

712

1.19

0.80

1.6

2.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.82

0.79

1.0

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

217

1.34

0.77

1.1

1.7

nmol/l

1.1

0.8

1.31

180

(3000963) Hemoglobin [Mass/volume] in Blood

1147

11280

1.12

0.74

65.5

18.8

g/l

122.9

137.3

109.04

1130

11050

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

158

1.40

0.74

2.1

2.5

u/l

2975.2

4417.4

—

(3007461) Platelets [#/volume] in Blood

1146

11270

1.12

0.74

65.0

18.7

e9/l

234.1

243.3

4.15

1122

10884

(40768795) Lymph node Pathology biopsy report

1.55

0.72

1.4

1.2

—

(3035941) MCH [Entitic mass]

1146

11275

1.12

0.72

64.6

18.6

30.0

30.5

12.82

1129

11045

(3024731) MCV [Entitic volume]

1146

11276

1.12

0.71

64.7

18.7

91.3

91.2

0.59

1129

11048

(3026361) Erythrocytes [#/volume] in Blood

1146

11277

1.12

0.70

64.9

18.7

e12/l

4.2

4.5

70.92

1120

10845

(3009466) Valproate [Moles/volume] in Serum or Plasma

152

1.39

0.69

3.9

4.5

umol/l

314.1

349.7

0.43

131

(3010813) Leukocytes [#/volume] in Blood

1146

11280

1.11

0.69

65.0

18.8

e9/l

7.3

6.8

10.24

1119

10851

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

341

0.76

0.68

2.0

1.4

mg/l

6.3

3.5

0.80

245

(3048879) Bone marrow aspiration report

1.79

0.66

1.6

1.8

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.79

0.66

1.0

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.79

0.66

1.4

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.67

0.61

1.0

1.2

—

(44813793)

1.57

0.60

1.1

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.60

0.0

2.9

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.60

0.0

5.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.54

0.59

1.0

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

318

1.23

0.59

2.0

—

(3014051) Protein [Presence] in Urine by Test strip

202

1.29

0.57

2.1

2.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

141

1.35

0.56

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

205

0.73

0.54

1.0

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

160

1.32

0.53

1.0

1.1

iu/ml

356.5

26.2

—

(4146454)

133

0.67

0.52

2.4

2.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

135

0.66

0.51

1.4

1.5

—

(44806420)

1.50

0.51

2.2

2.6

—

(1002224) Polysomnography panel

336

0.80

0.51

1.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

242

1.25

0.51

3.4

3.7

u/ml

52.1

1479.9

0.78

230

(3051387) C reactive protein [Mass/volume] in Capillary blood

247

0.77

0.50

3.5

3.0

mg/l

42.0

28.8

0.59

145

(3032773) Endomysium IgG Ab [Titer] in Serum

1.39

0.50

1.1

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.59

0.45

1.6

1.7

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

1.40

0.45

1.4

u/l

6.3

8.7

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

1.45

0.44

1.2

1.1

mg/l

41.0

47.7

—

(3045414) Leukocytes [Presence] in Urine

424

1.16

0.43

1.8

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1000

9847

1.06

0.42

5.0

4.5

mmol/l

6.2

6.0

2.30

925

8819

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

537

5541

0.95

0.42

4.7

5.2

ug/l

2.7

3.6

0.47

472

5011

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.41

0.42

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1.52

0.41

1.4

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

12.5

—

0.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.47

0.40

1.6

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1027

10129

1.06

0.39

5.5

4.8

mmol/l

2.4

2.7

26.91

961

9189

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.39

0.0

3.7

—

38.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.35

0.38

1.1

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

299

1.18

0.37

2.1

1.7

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.27

0.36

10.4

2.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.34

0.34

2.3

1.3

—

(40761535) Cells panel - Urine sediment

866

1.09

0.33

5.2

3.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

249

1.17

0.30

2.2

1.9

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1.29

0.30

1.1

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

113

1.24

0.26

1.0

1.1

u/ml

12.9

7.9

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

0.67

0.26

1.0

—

0.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.67

0.26

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

737

0.92

0.26

1.4

—

(3045424) Erythrocytes [Presence] in Urine

180

1.17

0.23

1.5

1.3

—

(3008898) HLA-B27 [Presence]

276

1.13

0.22

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.21

0.0

1.5

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.21

0.0

1.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.21

0.0

13.8

—

(4094501)

239

1.13

0.21

1.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.16

0.21

1.2

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

0.21

0.0

4.9

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

127

1.18

0.19

1.1

—

15.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

232

1.12

0.18

1.4

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

416

0.94

0.12

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

117

1136

1.03

0.10

2.5

2.1

nmol/l

12.9

13.2

0.09

1007

(4010399)

688

0.96

0.10

1.3

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.09

0.09

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.09

0.09

1.0

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.09

0.09

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.79

0.08

1.0

1.7

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

143

0.91

0.07

1.8

ug/l

17.6

35.1

1.15

143

(4024509)

0.86

0.07

1.9

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.82

0.07

1.4

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

276

1.05

0.06

3.0

2.2

ug/min

264.0

105.3

0.78

165

(3009214) Lutropin [Units/volume] in Serum or Plasma

250

1.04

0.03

1.8

1.4

u/l

12.4

7.4

0.42

205

(3023323) Follitropin [Units/volume] in Serum or Plasma

193

1.04

0.01

1.5

1.4

iu/l

27.3

21.1

0.25

163

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

136

0.96

0.00

1.2

1.4

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

2.2

—

1.1

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1735.4

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.0

1.0

—

1.2

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.0

1.6

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.0

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

1.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.0

1.4

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

0.00

0.0

1.0

—

0.3

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.00

0.00

1.0

1.5

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.2

—

(3001729) Color of Synovial fluid

0.00

0.0

1.5

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

6.7

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.0

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.90

0.00

1.3

1.6

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.8

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

2.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_ENDOCARD and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_ENDOCARD	3.233 [2.73, 3.82]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.262

During the follow-up period (1.1.1998 — 31.12.2019), 1079 out of 2258 females with I9_ENDOCARD died.

Males

Parameter	HR [95% CI]	p-value
I9_ENDOCARD	2.642 [2.3, 3.03]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.007

During the follow-up period (1.1.1998 — 31.12.2019), 1780 out of 4294 males with I9_ENDOCARD died.

Mortality risk

Mortality risk for people of age

years, who have I9_ENDOCARD.

N-year risk	Females	Males
1	0.296%	0.476%
5	1.536%	3.215%
10	4.302%	7.882%
15	9.026%	14.271%
20	15.834%	23.785%

Relationships between endpoints

↥

Index endpoint: I9_ENDOCARD – Endocarditis

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Endocarditis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints